Shopping Cart

No products in the cart.

ISO/TR 12417-2:2017

$41.60

Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information

Published By Publication Date Number of Pages
ISO 2017-11 36
Guaranteed Safe Checkout
Categories: ,

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

ISO/TR 12417-2:2017 provides region-specific information for

– local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

– changes related to the drug containing part and how they are evaluated by the different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

ISO/TR 12417-2:2017 is considered also as a supplement to ISO 12417-1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. Requirements listed in this document also address VDDCPs that are not necessarily permanent implants.

ISO/TR 12417-2:2017
$41.60